Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotinamide Riboside in Paclitaxel-induced Peripheral Neuropathy
NCT03642990Phase 2Terminated
- Sponsor
- Donna Hammond
- Start
- Nov 2019
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nicotinamide riboside in chemotherapy-induced peripheral neuropathy (CIPN), sponsored by Donna Hammond. Started Nov 2019; status: terminated.
02
Drugs
nicotinamide riboside
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT03642990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03642990.